granisetron has been researched along with Urinary Bladder Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horita, H; Hotta, H; Kato, R; Kitamura, H; Kunishima, Y; Masumori, N; Takahashi, A; Takei, F | 1 |
| Hayashida, S; Hirasawa, T; Mitsui, H; Nasu, T; Shinohara, Y; Uchiyama, K | 1 |
| Hosaka, M; Kondoh, K; Kubota, Y; Masuda, M; Misaki, H; Noguchi, S; Sakuramoto, T; Shuin, T; Yao, M | 1 |
| Aoyama, H; Babaya, K; Hayashi, Y; Hiramatsu, T; Hirao, YK; Kaneko, Y; Maruyama, Y; Matsuki, H; Momose, H; Natsume, O; Ohara, S; Okajima, E; Ozono, S; Sasaki, K; Shiomi, T; Tabata, S; Takashima, K; Watanabe, S; Yamada, K; Yoshikawa, M | 1 |
| Akaza, H; Hattori, K; Hinotsu, S; Ishikawa, S; Koiso, K; Kondo, F; Noguchi, R; Ohtani, M; Uchida, K | 1 |
4 trial(s) available for granisetron and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
[The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer].
Topics: Aged; Angiotensin II; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Child; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Infusions, Intra-Arterial; Methylprednisolone; Nausea; Tegafur; Urinary Bladder Neoplasms; Vomiting | 1995 |
[M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Colony-Stimulating Factors; Doxorubicin; Female; Gastrointestinal Diseases; Granisetron; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neutropenia; Recombinant Proteins; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
[A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Na
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Male; Granisetron; Humans; Kidney Neoplasms; Male; Methylprednisolone; Middle Aged; Nausea; Prostatic Neoplasms; Registries; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting | 1997 |
Antiemetic efficacy of granisetron: a randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy.
Topics: Adolescent; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Nausea; Prospective Studies; Urinary Bladder Neoplasms; Vomiting, Anticipatory | 1999 |
1 other study(ies) available for granisetron and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dexamethasone; Drug Therapy, Combination; Female; Gemcitabine; Granisetron; Humans; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting | 2015 |